Granular Therapeutics Limited is a startup based in the United Kingdom, most recent round Seed.
Granular Therapeutics Limited is a startup based in the United Kingdom. Its most recent tracked round is Seed.
Granular Therapeutics Limited develops novel antibody therapeutics that selectively target mast cells for disease-modifying immune modulation in chronic inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.